🇺🇸 FDA
Patent

US 10875911

High affinity human antibodies to human angiopoietin-2

granted A61KA61K2039/505A61K31/513

Quick answer

US patent 10875911 (High affinity human antibodies to human angiopoietin-2) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/513, A61K38/1866, A61K38/1891